Literature DB >> 11798240

Pathogenesis of experimental Ebola Zaire virus infection in BALB/c mice.

T R Gibb1, M Bray, T W Geisbert, K E Steele, W M Kell, K J Davis, N K Jaax.   

Abstract

Guinea-pigs and non-human primates have traditionally been used as animal models for studying Ebola Zaire virus (EBO-Z) infections. The virus was also recently adapted to the stage of lethal virulence in BALB/c mice. This murine model is now in use for testing antiviral medications and vaccines. However, the pathological features of EBO-Z infection in mice have not yet been fully described. To identify sites of viral replication and characterize sequential morphological changes in BALB/c mice, adult female mice were infected with mouse-adapted EBO-Z and killed in groups each day for 5 days post-infection. Tissues were examined by light microscopy, immunohistochemistry, electron microscopy and in-situ hybridization. As in guinea-pigs and non-human primates, cells of the mononuclear phagocytic system were the earliest targets of infection. Viral replication was observed by day 2 in macrophages in lymph nodes and spleen. By the time of onset of illness and weight loss (day 3), the infection had spread to hepatocytes and adrenal cortical cells, and to macrophages and fibroblast-like cells in many organs. Severe lymphocytolysis was observed in the spleen, lymph nodes and thymus. There was minimal infection of endothelial cells. All of these changes resembled those observed in EBO-Z-infected guinea-pigs and non-human primates. In contrast to the other animal models, however, there was little fibrin deposition in the late stage of disease. The availability of immunodeficient, "gene-knockout" and transgenic mice will make the mouse model particularly useful for studying the early steps of Ebola pathogenesis. Copyright Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11798240     DOI: 10.1053/jcpa.2001.0502

Source DB:  PubMed          Journal:  J Comp Pathol        ISSN: 0021-9975            Impact factor:   1.311


  57 in total

1.  The Tyro3 receptor kinase Axl enhances macropinocytosis of Zaire ebolavirus.

Authors:  Catherine L Hunt; Andrey A Kolokoltsov; Robert A Davey; Wendy Maury
Journal:  J Virol       Date:  2010-11-03       Impact factor: 5.103

2.  Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1.

Authors:  St Patrick Reid; Charalampos Valmas; Osvaldo Martinez; Freddy Mauricio Sanchez; Christopher F Basler
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

3.  Functional genomics reveals the induction of inflammatory response and metalloproteinase gene expression during lethal Ebola virus infection.

Authors:  Cristian Cilloniz; Hideki Ebihara; Chester Ni; Gabriele Neumann; Marcus J Korth; Sara M Kelly; Yoshihiro Kawaoka; Heinz Feldmann; Michael G Katze
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

Review 4.  Animal Models of Ebolavirus Infection.

Authors:  Marisa C St Claire; Dan R Ragland; Laura Bollinger; Peter B Jahrling
Journal:  Comp Med       Date:  2017-06-01       Impact factor: 0.982

5.  Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection.

Authors:  Erica Ollmann Saphire; Sharon L Schendel; Marnie L Fusco; Karthik Gangavarapu; Bronwyn M Gunn; Anna Z Wec; Peter J Halfmann; Jennifer M Brannan; Andrew S Herbert; Xiangguo Qiu; Kshitij Wagh; Shihua He; Elena E Giorgi; James Theiler; Kathleen B J Pommert; Tyler B Krause; Hannah L Turner; Charles D Murin; Jesper Pallesen; Edgar Davidson; Rafi Ahmed; M Javad Aman; Alexander Bukreyev; Dennis R Burton; James E Crowe; Carl W Davis; George Georgiou; Florian Krammer; Christos A Kyratsous; Jonathan R Lai; Cory Nykiforuk; Michael H Pauly; Pramila Rijal; Ayato Takada; Alain R Townsend; Viktor Volchkov; Laura M Walker; Cheng-I Wang; Larry Zeitlin; Benjamin J Doranz; Andrew B Ward; Bette Korber; Gary P Kobinger; Kristian G Andersen; Yoshihiro Kawaoka; Galit Alter; Kartik Chandran; John M Dye
Journal:  Cell       Date:  2018-08-09       Impact factor: 41.582

6.  A Systems Approach Reveals MAVS Signaling in Myeloid Cells as Critical for Resistance to Ebola Virus in Murine Models of Infection.

Authors:  Mukta Dutta; Shelly J Robertson; Atsushi Okumura; Dana P Scott; Jean Chang; Jeffrey M Weiss; Gail L Sturdevant; Friederike Feldmann; Elaine Haddock; Abhilash I Chiramel; Sanket S Ponia; Jonathan D Dougherty; Michael G Katze; Angela L Rasmussen; Sonja M Best
Journal:  Cell Rep       Date:  2017-01-17       Impact factor: 9.423

7.  Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis.

Authors:  Nadia Wauquier; Pierre Becquart; Cindy Padilla; Sylvain Baize; Eric M Leroy
Journal:  PLoS Negl Trop Dis       Date:  2010-10-05

8.  Experimental respiratory Marburg virus haemorrhagic fever infection in the common marmoset (Callithrix jacchus).

Authors:  Sophie J Smither; Michelle Nelson; Lin Eastaugh; Thomas R Laws; Christopher Taylor; Simon A Smith; Francisco J Salguero; Mark S Lever
Journal:  Int J Exp Pathol       Date:  2013-02-27       Impact factor: 1.925

9.  Whole-genome expression profiling reveals that inhibition of host innate immune response pathways by Ebola virus can be reversed by a single amino acid change in the VP35 protein.

Authors:  Amy L Hartman; Ling Ling; Stuart T Nichol; Martin L Hibberd
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

10.  Prevention of immune cell apoptosis as potential therapeutic strategy for severe infections.

Authors:  Janie Parrino; Richard S Hotchkiss; Mike Bray
Journal:  Emerg Infect Dis       Date:  2007-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.